MENU
NUVB
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Nuvation Bio (NUVB) Earnings Date & Reports

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

A.I. Advisor
published Earnings

NUVB is expected to report earnings to fall 33.33% to -11 cents per share on November 02

Nuvation Bio NUVB Stock Earnings Reports
Q3'26
Est.
$-0.12
Q2'26
Missed
by $0.03
Q1'26
Est.
$0.01
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 5.80M shares outstanding, the current market capitalization sits at 1.70B.